Advisory Council for the Elimination of Tuberculosis Meeting (ACET), 32124 [2018-14755]
Download as PDF
<![CDATA[
32124
Federal Register / Vol. 83, No. 133 / Wednesday, July 11, 2018 / Notices
category for purposes of applying the
disclosure thresholds.
OGE is also proposing to update the
Privacy Act Statement in accordance
with changes to the applicable system of
records, update the examples provided
on the last page of the form, and make
other minor technical changes.
Request for Comments: OGE is
publishing this first round notice of its
intent to request paperwork clearance
for a proposed modified OGE Form 450.
Public comment is invited specifically
on the need for and practical utility of
this information collection, the accuracy
of OGE’s burden estimate, the
enhancement of quality, utility and
clarity of the information collected, and
the minimization of burden (including
the use of information technology).
Comments received in response to this
notice will be summarized for, and may
be included with, the OGE request for
extension of OMB paperwork approval.
The comments will also become a
matter of public record.
Approved: July 3, 2018.
David Apol,
Acting Director and General Counsel, Office
of Government Ethics.
[FR Doc. 2018–14841 Filed 7–10–18; 8:45 am]
BILLING CODE 6345–03–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Council for the Elimination of
Tuberculosis Meeting (ACET)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
of the Advisory Council for the
Elimination of Tuberculosis Meeting
(ACET). This meeting is open to the
public, limited only by 60 room seating
and 100 ports for audio phone lines.
Time will be available for public
comment. The public is welcome to
submit written comments in advance of
the meeting. Comments should be
submitted in writing by email to the
contact person listed below. The
deadline for receipt is Monday, August
13, 2018. Persons who desire to make an
oral statement, may request it at the
time of the public comment period on
August 21, 2018 at 3:20 p.m., EDT.
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:26 Jul 10, 2018
Jkt 244001
The meeting will be held on
August 21, 2018, 10:00 a.m. to 3:30
p.m., EDT.
DATES:
8 Corporate Blvd., Building
8, Conference Rooms 1A and 1B,
Atlanta, Georgia 30329 and Web
conference: 1–877–927–1433 and
participant passcode: 12016435 and
https://adobeconnect.cdc.gov/
r5p8l2tytpq/.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Margie Scott-Cseh, Committee
Management Specialist, CDC, 1600
Clifton Road NE, Mailstop: E–07,
Atlanta, Georgia 30329–4018, telephone
(404) 639–8317; zkr7@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: This Council advises and
makes recommendations to the
Secretary of Health and Human
Services, the Assistant Secretary for
Health, and the Director, CDC, regarding
the elimination of tuberculosis.
Specifically, the Council makes
recommendations regarding policies,
strategies, objectives, and priorities;
addresses the development and
application of new technologies; and
reviews the extent to which progress has
been made toward eliminating
tuberculosis.
Matters To Be Considered: The agenda
will include discussions on (1)
Isoniazid-Rifapentine TB Prevention in
HIV-infected Persons Study; (2) Division
of HIV/AIDS Prevention’s Strategy of
Adopting HIV Treatment as Prevention;
(3) Update on Division of Tuberculosis
Elimination’s Concept of Operations for
Latent Tuberculosis Infection
Surveillance; and (4) Update from ACET
workgroups. Agenda items are subject to
change as priorities dictate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–14755 Filed 7–10–18; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Breast Cancer
in Young Women, Centers for Disease
Control and Prevention; Notice of
Charter Renewal
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of charter renewal.
AGENCY:
This gives notice under the
Federal Advisory Committee Act of
October 6, 1972, that the Advisory
Committee on Breast Cancer in Young
Women (ACBCYW), Centers for Disease
Control and Prevention, Department of
Health and Human Services, has been
renewed for a 2-year period through
June 17, 2020.
FOR FURTHER INFORMATION CONTACT:
Temeika L. Fairley, Ph.D., Designated
Federal Officer, National Center for
Chronic Disease Prevention and Health
Promotion, CDC, 5770 Buford Highway
NE, Mailstop K52, Atlanta, Georgia
30341, Telephone (770) 488–4518, Fax
(770) 488–4760. Email: acbcyw@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
SUMMARY:
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–14756 Filed 7–10–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–18–0572]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Health Message
Testing System (HMTS) to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
E:\FR\FM\11JYN1.SGM
11JYN1
]]>Agencies
[Federal Register Volume 83, Number 133 (Wednesday, July 11, 2018)]
[Notices]
[Page 32124]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-14755]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Council for the Elimination of Tuberculosis Meeting
(ACET)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting of the Advisory Council for the
Elimination of Tuberculosis Meeting (ACET). This meeting is open to the
public, limited only by 60 room seating and 100 ports for audio phone
lines. Time will be available for public comment. The public is welcome
to submit written comments in advance of the meeting. Comments should
be submitted in writing by email to the contact person listed below.
The deadline for receipt is Monday, August 13, 2018. Persons who desire
to make an oral statement, may request it at the time of the public
comment period on August 21, 2018 at 3:20 p.m., EDT.
DATES: The meeting will be held on August 21, 2018, 10:00 a.m. to 3:30
p.m., EDT.
ADDRESSES: 8 Corporate Blvd., Building 8, Conference Rooms 1A and 1B,
Atlanta, Georgia 30329 and Web conference: 1-877-927-1433 and
participant passcode: 12016435 and https://adobeconnect.cdc.gov/r5p8l2tytpq/.
FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee
Management Specialist, CDC, 1600 Clifton Road NE, Mailstop: E-07,
Atlanta, Georgia 30329-4018, telephone (404) 639-8317; [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: This Council advises and makes recommendations to the
Secretary of Health and Human Services, the Assistant Secretary for
Health, and the Director, CDC, regarding the elimination of
tuberculosis. Specifically, the Council makes recommendations regarding
policies, strategies, objectives, and priorities; addresses the
development and application of new technologies; and reviews the extent
to which progress has been made toward eliminating tuberculosis.
Matters To Be Considered: The agenda will include discussions on
(1) Isoniazid-Rifapentine TB Prevention in HIV-infected Persons Study;
(2) Division of HIV/AIDS Prevention's Strategy of Adopting HIV
Treatment as Prevention; (3) Update on Division of Tuberculosis
Elimination's Concept of Operations for Latent Tuberculosis Infection
Surveillance; and (4) Update from ACET workgroups. Agenda items are
subject to change as priorities dictate.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2018-14755 Filed 7-10-18; 8:45 am]
BILLING CODE 4163-18-P
